Shareholders of Perspective Therapeutics (NYSE: CATX) back board, auditor
Filing Impact
Filing Sentiment
Form Type
8-K
Rhea-AI Filing Summary
Perspective Therapeutics, Inc. reported the results of its 2026 Annual Meeting of Stockholders. Of 114,017,755 common shares entitled to vote, 97,882,462 shares were represented, an 85.85% quorum. Stockholders elected six directors to serve until the 2027 annual meeting.
They also ratified WithumSmith+Brown, PC as independent registered public accounting firm for the fiscal year ending December 31, 2026. In an advisory vote on the frequency of say-on-pay, a one-year interval received the most support, and the company intends to hold annual advisory votes on executive compensation.
Positive
- None.
Negative
- None.
8-K Event Classification
Item 5.07 — Submission of Matters to a Vote of Security Holders
1 item
Item 5.07
Submission of Matters to a Vote of Security Holders
Governance
Results of a shareholder vote on proposals at an annual or special meeting.
Key Figures
Shares outstanding entitled to vote: 114,017,755 shares
Shares represented at meeting: 97,882,462 shares
Quorum percentage: 85.85%
+4 more
7 metrics
Shares outstanding entitled to vote
114,017,755 shares
Common stock outstanding and entitled to vote at 2026 annual meeting
Shares represented at meeting
97,882,462 shares
Shares represented in person or by proxy, 85.85% quorum
Quorum percentage
85.85%
Percentage of entitled shares represented at 2026 annual meeting
Auditor ratification votes for
97,636,978 votes
Votes for ratifying WithumSmith+Brown, PC for year ending December 31, 2026
Auditor ratification votes against
125,426 votes
Votes against ratifying WithumSmith+Brown, PC
Say-on-pay 1-year frequency votes
76,479,166 votes
Votes favoring annual advisory vote on executive compensation
Broker non-votes on director elections
20,599,237 votes
Broker non-votes recorded for each director nominee
Key Terms
broker non-votes, independent registered public accounting firm, non-binding advisory basis, emerging growth company, +1 more
5 terms
broker non-votes financial
"The votes were cast as follows Nominee | For | Withheld | Broker Non-Votes"
Broker non-votes occur when a brokerage firm is unable to vote on a shareholder’s behalf during a company election or decision because the shareholder has not given specific voting instructions, and the broker is not allowed or chooses not to vote on certain matters. They are important because they can affect the outcome of votes, especially when the results are close, by effectively reducing the total number of votes cast.
independent registered public accounting firm financial
"ratified the appointment of WithumSmith+Brown, PC as the Company’s independent registered public accounting firm"
An independent registered public accounting firm is an outside accounting company officially registered with the government regulator to examine and report on a public company's financial records and controls. Investors treat its reports like an impartial inspector’s certificate — they add credibility to financial statements, help spot errors or misleading claims, and reduce the risk that shareholders are relying on unchecked or biased numbers.
non-binding advisory basis financial
"The stockholders of the Company voted, on a non-binding advisory basis, on how frequently future non-binding advisory votes"
A non-binding advisory basis is guidance or a recommendation offered for informational purposes that does not create legal obligations or guarantees; recipients can accept, modify, or ignore it without contractual consequences. Investors should treat it like a weather forecast for planning—useful for forming expectations and assessing risk, but not a firm promise—so they should verify assumptions, seek confirming information, and avoid relying on it as the sole basis for investment decisions.
emerging growth company regulatory
"Emerging growth company Item 5.07 Submission of Matters to a Vote of Security Holders."
An emerging growth company is a recently public or smaller public firm that qualifies for temporary, lighter regulatory and disclosure rules to reduce the cost and effort of being public. For investors, it means the company may provide less historical financial detail and face fewer reporting requirements than larger firms, so it can grow more quickly but also carries higher uncertainty—like buying a promising early-stage product with fewer user reviews.
Annual Meeting of Stockholders financial
"held its 2026 Annual Meeting of Stockholders (the “Annual Meeting”)."
FAQ
Which directors were elected at Perspective Therapeutics (CATX) 2026 annual meeting?
Stockholders elected Lori A. Woods, Heidi Henson, Maya Martinez-Davis, Frank Morich, M.D., Ph.D., Johan (Thijs) Spoor and Robert Froman Williamson, III. Each will serve on the board until the 2027 annual meeting and until a successor is elected and qualified.
What frequency of executive compensation votes will Perspective Therapeutics (CATX) adopt?
In light of the advisory vote results and other factors, the board intends to hold a non-binding advisory stockholder vote on named executive officer compensation on an annual basis, until the next required vote on say-on-pay frequency or a different frequency is determined.